These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 12699023

  • 41. The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial.
    Walker N, Howe C, Bullen C, Grigg M, Glover M, McRobbie H, Laugesen M, Parag V, Whittaker R.
    Addiction; 2012 Oct; 107(10):1857-67. PubMed ID: 22594651
    [Abstract] [Full Text] [Related]

  • 42. Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?
    Rezaishiraz H, Hyland A, Mahoney MC, O'Connor RJ, Cummings KM.
    Nicotine Tob Res; 2007 Nov; 9(11):1139-46. PubMed ID: 17978987
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Relationships Between Craving Beliefs and Abstinence Self-Efficacy are Mediated by Smoking Motives and Moderated by Nicotine Dependence.
    Reese ED, Veilleux JC.
    Nicotine Tob Res; 2016 Jan; 18(1):48-55. PubMed ID: 25744968
    [Abstract] [Full Text] [Related]

  • 46. Meta-analysis of studies investigating one-year effectiveness of transdermal nicotine patches for smoking cessation.
    Myung SK, Yoo KY, Oh SW, Park SH, Seo HG, Hwang SS, Park SK.
    Am J Health Syst Pharm; 2007 Dec 01; 64(23):2471-6. PubMed ID: 18029953
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial.
    Lerman C, Kaufmann V, Rukstalis M, Patterson F, Perkins K, Audrain-McGovern J, Benowitz N.
    Ann Intern Med; 2004 Mar 16; 140(6):426-33. PubMed ID: 15023708
    [Abstract] [Full Text] [Related]

  • 49. Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials.
    Hays JT, Croghan IT, Schroeder DR, Offord KP, Hurt RD, Wolter TD, Nides MA, Davidson M.
    Am J Public Health; 1999 Nov 16; 89(11):1701-7. PubMed ID: 10553392
    [Abstract] [Full Text] [Related]

  • 50. Smoking relapse and weight gain prevention program for postmenopausal weight-concerned women: A pilot study.
    Copeland AL, McVay MA, Martin PD, Rash CJ, Kendzor DE, Baillie LE, Spears CA, Geiselman PJ.
    Eat Behav; 2015 Aug 16; 18():107-14. PubMed ID: 26026615
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. A placebo controlled randomized trial of the effects of phenylpropanolamine and nicotine gum on cessation rates and postcessation weight gain in women.
    Cooper TV, Klesges RC, Debon MW, Zbikowski SM, Johnson KC, Clemens LH.
    Addict Behav; 2005 Jan 16; 30(1):61-75. PubMed ID: 15561449
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Smoking-cessation treatment combining transdermal nicotine substitution with behavioral therapy.
    Buchkremer G, Minneker E, Block M.
    Pharmacopsychiatry; 1991 May 16; 24(3):96-102. PubMed ID: 1891488
    [Abstract] [Full Text] [Related]

  • 55. Long-term nicotine replacement therapy: a randomized clinical trial.
    Schnoll RA, Goelz PM, Veluz-Wilkins A, Blazekovic S, Powers L, Leone FT, Gariti P, Wileyto EP, Hitsman B.
    JAMA Intern Med; 2015 Apr 16; 175(4):504-11. PubMed ID: 25705872
    [Abstract] [Full Text] [Related]

  • 56. Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study.
    Batra A, Klingler K, Landfeldt B, Friederich HM, Westin A, Danielsson T.
    Clin Pharmacol Ther; 2005 Dec 16; 78(6):689-96. PubMed ID: 16338284
    [Abstract] [Full Text] [Related]

  • 57. OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences.
    Covey LS, Hu MC, Winhusen T, Weissman J, Berlin I, Nunes EV.
    Drug Alcohol Depend; 2010 Jul 01; 110(1-2):156-9. PubMed ID: 20219292
    [Abstract] [Full Text] [Related]

  • 58. The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression.
    Thorsteinsson HS, Gillin JC, Patten CA, Golshan S, Sutton LD, Drummond S, Clark CP, Kelsoe J, Rapaport M.
    Neuropsychopharmacology; 2001 Apr 01; 24(4):350-8. PubMed ID: 11182530
    [Abstract] [Full Text] [Related]

  • 59. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia.
    George TP, Ziedonis DM, Feingold A, Pepper WT, Satterburg CA, Winkel J, Rounsaville BJ, Kosten TR.
    Am J Psychiatry; 2000 Nov 01; 157(11):1835-42. PubMed ID: 11058482
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.